The 44 rating InvestorsObserver gives to Cyclacel Pharmaceuticals Inc (CYCC) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 38 percent of stocks in the Biotechnology industry, CYCC’s 44 overall rating means the stock scores better than 44 percent of all stocks.
CYCC has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on CYCC!